Menopause Treatment Market 2027 by Hormonal Treatment, Non-Hormonal Treatment, End User and Geography | The Insight Partners

Menopause Treatment Market to 2027 - Global Analysis and Forecasts By Hormonal Treatment (Estrogen, Progesterone, Combination); Non-Hormonal Treatment (Anti-Depressants, Anti-Migraine, Anti-Anxiety); End User (Hospitals & Clinics, Academic & Research Institutes, Others), and Geography

Report Code: TIPRE00006849 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Menopause is known as the stage of the end of the fertile phase in women, which occurs typically at the age of 40 most women. Menopause affects reduced estrogen production and grown gonadotropin, which results in the termination of the menstrual cycle and menstrual flow. These physiological changes cause vasomotor symptoms. Vasomotor symptoms are changes between two phases that are peri-menopause and menopause.

MARKET DYNAMICS

Menopause treatment market is anticipated to grow in the forecast period owing to driving factors such as rise in geriatric population and growing awareness about women health. Moreover, development of healthcare and gynecology centres, and development in drugs specially the advancements in hormonal drugs etc. is also offering opportunity in the market growth during the forecast period.

MARKET SCOPE

The "Global Menopause Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of menopause treatment market with detailed market segmentation by hormonal treatment, non-hormonal treatment, end user, and geography. The global menopause treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading menopause treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global menopause treatment market is segmented on the basis of hormonal treatment, non-hormonal treatment and end user. Based on hormonal treatment, the market is segmented as estrogen, progesterone, and combination. Based on non-hormonal treatment, the market is segmented as anti-depressants, anti-migraine, and anti-anxiety. Based on end user, the market is segmented as hospitals & clinics, academic & research institutes, and others.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global menopause treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The menopause treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting menopause treatment market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the menopause treatment market in these regions.

MARKET PLAYERS


The report covers key developments in the menopause treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from menopause treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for menopause treatment in the global market. Below mentioned is the list of few companies engaged in the menopause treatment market.

The report also includes the profiles of key menopause treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Merck & Co., Inc.
  •  Novartis AG
  •  Novo Nordisk A/S
  •  Pfizer, Inc.
  •  Allergan plc.
  •  Emcure Pharmaceuticals Ltd.
  •  Eli Lilly and Company
  •  Cipla Inc.
  •  Teva Pharmaceutical Industries Ltd.
  •  Glenmark Pharmaceuticals Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Table of Content

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Menopause Treatment Market - By Hormonal Treatment
1.3.2 Menopause Treatment Market - By Non-Hormonal Treatment
1.3.3 Menopause Treatment Market - By End User
1.3.4 Menopause Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. MENOPAUSE TREATMENT MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. MENOPAUSE TREATMENT MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. MENOPAUSE TREATMENT MARKET - GLOBAL MARKET ANALYSIS

6.1. MENOPAUSE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. MENOPAUSE TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. MENOPAUSE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - HORMONAL TREATMENT

7.1. OVERVIEW
7.2. HORMONAL TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. ESTROGEN
7.3.1. Overview
7.3.2. Estrogen Market Forecast and Analysis
7.4. PROGESTERONE
7.4.1. Overview
7.4.2. Progesterone Market Forecast and Analysis
7.5. COMBINATION
7.5.1. Overview
7.5.2. Combination Market Forecast and Analysis

8. MENOPAUSE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - NON-HORMONAL TREATMENT

8.1. OVERVIEW
8.2. NON-HORMONAL TREATMENT MARKET FORECASTS AND ANALYSIS
8.3. ANTI-DEPRESSANTS
8.3.1. Overview
8.3.2. Anti-Depressants Market Forecast and Analysis
8.4. ANTI-MIGRAINE
8.4.1. Overview
8.4.2. Anti-Migraine Market Forecast and Analysis
8.5. ANTI-ANXIETY
8.5.1. Overview
8.5.2. Anti-Anxiety Market Forecast and Analysis

9. MENOPAUSE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER

9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. ACADEMIC AND RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academic And Research Institutes Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. MENOPAUSE TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Menopause Treatment Market Overview
10.1.2 North America Menopause Treatment Market Forecasts and Analysis
10.1.3 North America Menopause Treatment Market Forecasts and Analysis - By Hormonal Treatment
10.1.4 North America Menopause Treatment Market Forecasts and Analysis - By Non-Hormonal Treatment
10.1.5 North America Menopause Treatment Market Forecasts and Analysis - By End User
10.1.6 North America Menopause Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Menopause Treatment Market
10.1.6.1.1 United States Menopause Treatment Market by Hormonal Treatment
10.1.6.1.2 United States Menopause Treatment Market by Non-Hormonal Treatment
10.1.6.1.3 United States Menopause Treatment Market by End User
10.1.6.2 Canada Menopause Treatment Market
10.1.6.2.1 Canada Menopause Treatment Market by Hormonal Treatment
10.1.6.2.2 Canada Menopause Treatment Market by Non-Hormonal Treatment
10.1.6.2.3 Canada Menopause Treatment Market by End User
10.1.6.3 Mexico Menopause Treatment Market
10.1.6.3.1 Mexico Menopause Treatment Market by Hormonal Treatment
10.1.6.3.2 Mexico Menopause Treatment Market by Non-Hormonal Treatment
10.1.6.3.3 Mexico Menopause Treatment Market by End User
10.2. EUROPE
10.2.1 Europe Menopause Treatment Market Overview
10.2.2 Europe Menopause Treatment Market Forecasts and Analysis
10.2.3 Europe Menopause Treatment Market Forecasts and Analysis - By Hormonal Treatment
10.2.4 Europe Menopause Treatment Market Forecasts and Analysis - By Non-Hormonal Treatment
10.2.5 Europe Menopause Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe Menopause Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Menopause Treatment Market
10.2.6.1.1 Germany Menopause Treatment Market by Hormonal Treatment
10.2.6.1.2 Germany Menopause Treatment Market by Non-Hormonal Treatment
10.2.6.1.3 Germany Menopause Treatment Market by End User
10.2.6.2 France Menopause Treatment Market
10.2.6.2.1 France Menopause Treatment Market by Hormonal Treatment
10.2.6.2.2 France Menopause Treatment Market by Non-Hormonal Treatment
10.2.6.2.3 France Menopause Treatment Market by End User
10.2.6.3 Italy Menopause Treatment Market
10.2.6.3.1 Italy Menopause Treatment Market by Hormonal Treatment
10.2.6.3.2 Italy Menopause Treatment Market by Non-Hormonal Treatment
10.2.6.3.3 Italy Menopause Treatment Market by End User
10.2.6.4 Spain Menopause Treatment Market
10.2.6.4.1 Spain Menopause Treatment Market by Hormonal Treatment
10.2.6.4.2 Spain Menopause Treatment Market by Non-Hormonal Treatment
10.2.6.4.3 Spain Menopause Treatment Market by End User
10.2.6.5 United Kingdom Menopause Treatment Market
10.2.6.5.1 United Kingdom Menopause Treatment Market by Hormonal Treatment
10.2.6.5.2 United Kingdom Menopause Treatment Market by Non-Hormonal Treatment
10.2.6.5.3 United Kingdom Menopause Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Menopause Treatment Market Overview
10.3.2 Asia-Pacific Menopause Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Menopause Treatment Market Forecasts and Analysis - By Hormonal Treatment
10.3.4 Asia-Pacific Menopause Treatment Market Forecasts and Analysis - By Non-Hormonal Treatment
10.3.5 Asia-Pacific Menopause Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Menopause Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Menopause Treatment Market
10.3.6.1.1 Australia Menopause Treatment Market by Hormonal Treatment
10.3.6.1.2 Australia Menopause Treatment Market by Non-Hormonal Treatment
10.3.6.1.3 Australia Menopause Treatment Market by End User
10.3.6.2 China Menopause Treatment Market
10.3.6.2.1 China Menopause Treatment Market by Hormonal Treatment
10.3.6.2.2 China Menopause Treatment Market by Non-Hormonal Treatment
10.3.6.2.3 China Menopause Treatment Market by End User
10.3.6.3 India Menopause Treatment Market
10.3.6.3.1 India Menopause Treatment Market by Hormonal Treatment
10.3.6.3.2 India Menopause Treatment Market by Non-Hormonal Treatment
10.3.6.3.3 India Menopause Treatment Market by End User
10.3.6.4 Japan Menopause Treatment Market
10.3.6.4.1 Japan Menopause Treatment Market by Hormonal Treatment
10.3.6.4.2 Japan Menopause Treatment Market by Non-Hormonal Treatment
10.3.6.4.3 Japan Menopause Treatment Market by End User
10.3.6.5 South Korea Menopause Treatment Market
10.3.6.5.1 South Korea Menopause Treatment Market by Hormonal Treatment
10.3.6.5.2 South Korea Menopause Treatment Market by Non-Hormonal Treatment
10.3.6.5.3 South Korea Menopause Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Menopause Treatment Market Overview
10.4.2 Middle East and Africa Menopause Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Menopause Treatment Market Forecasts and Analysis - By Hormonal Treatment
10.4.4 Middle East and Africa Menopause Treatment Market Forecasts and Analysis - By Non-Hormonal Treatment
10.4.5 Middle East and Africa Menopause Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Menopause Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Menopause Treatment Market
10.4.6.1.1 South Africa Menopause Treatment Market by Hormonal Treatment
10.4.6.1.2 South Africa Menopause Treatment Market by Non-Hormonal Treatment
10.4.6.1.3 South Africa Menopause Treatment Market by End User
10.4.6.2 Saudi Arabia Menopause Treatment Market
10.4.6.2.1 Saudi Arabia Menopause Treatment Market by Hormonal Treatment
10.4.6.2.2 Saudi Arabia Menopause Treatment Market by Non-Hormonal Treatment
10.4.6.2.3 Saudi Arabia Menopause Treatment Market by End User
10.4.6.3 U.A.E Menopause Treatment Market
10.4.6.3.1 U.A.E Menopause Treatment Market by Hormonal Treatment
10.4.6.3.2 U.A.E Menopause Treatment Market by Non-Hormonal Treatment
10.4.6.3.3 U.A.E Menopause Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Menopause Treatment Market Overview
10.5.2 South and Central America Menopause Treatment Market Forecasts and Analysis
10.5.3 South and Central America Menopause Treatment Market Forecasts and Analysis - By Hormonal Treatment
10.5.4 South and Central America Menopause Treatment Market Forecasts and Analysis - By Non-Hormonal Treatment
10.5.5 South and Central America Menopause Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America Menopause Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Menopause Treatment Market
10.5.6.1.1 Brazil Menopause Treatment Market by Hormonal Treatment
10.5.6.1.2 Brazil Menopause Treatment Market by Non-Hormonal Treatment
10.5.6.1.3 Brazil Menopause Treatment Market by End User
10.5.6.2 Argentina Menopause Treatment Market
10.5.6.2.1 Argentina Menopause Treatment Market by Hormonal Treatment
10.5.6.2.2 Argentina Menopause Treatment Market by Non-Hormonal Treatment
10.5.6.2.3 Argentina Menopause Treatment Market by End User

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. MENOPAUSE TREATMENT MARKET, KEY COMPANY PROFILES

12.1. MERCK AND CO., INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVO NORDISK A/S
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ALLERGAN PLC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EMCURE PHARMACEUTICALS LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELI LILLY AND COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CIPLA INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GLENMARK PHARMACEUTICALS LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Merck & Co., Inc.
2. Novartis AG
3. Novo Nordisk A/S
4. Pfizer, Inc.
5. Allergan plc.
6. Emcure Pharmaceuticals Ltd.
7. Eli Lilly and Company
8. Cipla Inc.
9. Teva Pharmaceutical Industries Ltd.
10. Glenmark Pharmaceuticals Ltd.